BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34867985)

  • 1. A New Murine Model of Primary Autoimmune Hemolytic Anemia (AIHA).
    Dei Zotti F; Qiu A; La Carpia F; Moriconi C; Hudson KE
    Front Immunol; 2021; 12():752330. PubMed ID: 34867985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine models of autoimmune hemolytic anemia.
    Howie HL; Hudson KE
    Curr Opin Hematol; 2018 Nov; 25(6):473-481. PubMed ID: 30169458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerization of recent thymic emigrants is required to prevent RBC-specific autoimmunity.
    Wong ASL; Gruber DR; Richards AL; Sheldon K; Qiu A; Hay A; Hudson KE
    J Autoimmun; 2020 Nov; 114():102489. PubMed ID: 32507505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of immunological tolerance loss versus erythrocyte self-antigens and autoimmune hemolytic anemia.
    Fagiolo E; Toriani-Terenzi C
    Autoimmunity; 2003 Jun; 36(4):199-204. PubMed ID: 14563012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune hemolytic anemia in hospitalized patients: 450 patients and their red blood cell transfusions.
    Chen C; Wang L; Han B; Qin L; Ying B
    Medicine (Baltimore); 2020 Jan; 99(2):e18739. PubMed ID: 31914091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-33 reflects dynamics of disease activity in patients with autoimmune hemolytic anemia by regulating autoantibody production.
    Bu X; Zhang T; Wang C; Ren T; Wen Z
    J Transl Med; 2015 Dec; 13():381. PubMed ID: 26675669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serological characteristics and transfusion efficacy evaluation in 61 cases of autoimmune hemolytic anemia].
    Yu Y; Sun XL; Ma CY; Guan XZ; Zhang XJ; Chen LF; Wang K; Luo YY; Wang Y; Li MW; Feng YN; Tong S; Yu S; Yang L; Wu YQ; Zhuang Y; Pan JC; Fen Q; Zhang T; Wang DQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1275-9. PubMed ID: 24156449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warm autoimmune hemolytic anemia: recent progress in understanding the immunobiology and the treatment.
    Barros MM; Blajchman MA; Bordin JO
    Transfus Med Rev; 2010 Jul; 24(3):195-210. PubMed ID: 20656187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autoimmune hemolytic anemia].
    Karasawa M
    Nihon Rinsho; 2008 Mar; 66(3):520-3. PubMed ID: 18326320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron metabolism abnormalities in autoimmune hemolytic anemia and
    Zhao M; Wang Y; Yang J; Wang Y; Feng Y; Chen L; Shao Z; Wang H; Xing L
    Ann Med; 2023 Dec; 55(1):231-240. PubMed ID: 36576329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of Th17 cells in development of autoimmune hemolytic anemia.
    Xu L; Zhang T; Liu Z; Li Q; Xu Z; Ren T
    Exp Hematol; 2012 Dec; 40(12):994-1004.e4. PubMed ID: 22960264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune hemolytic anemia.
    Čermák J; Písačka M
    Vnitr Lek; 2018; 64(5):514-519. PubMed ID: 30193520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of D- red blood cell transfusion and rituximab therapy in autoimmune hemolytic anemia with anti-D and panreactive autoantibodies arising after hematopoietic stem cell transplant.
    Minakawa K; Ohto H; Yasuda H; Saito S; Kawabata K; Ogawa K; Nollet KE; Ikeda K
    Transfusion; 2018 Jul; 58(7):1606-1610. PubMed ID: 29664112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of autoimmune hemolytic anemia in beta-thalassemia patients with underlying red blood cells autoantibodies.
    Khaled MB; Ouederni M; Sahli N; Dhouib N; Abdelaziz AB; Rekaya S; Kouki R; Kaabi H; Slama H; Mellouli F; Bejaoui M
    Blood Cells Mol Dis; 2019 Nov; 79():102342. PubMed ID: 31302454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case report: exacerbation of hemolytic anemia requiring multiple incompatible RBC transfusions.
    Svensson AM; Bushor S; Fung MK
    Immunohematology; 2004; 20(3):177-83. PubMed ID: 15373649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune pathogenesis and autoimmune hemolytic anemia.
    Semple JW; Freedman J
    Semin Hematol; 2005 Jul; 42(3):122-30. PubMed ID: 16041661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy.
    Berentsen S; Sundic T
    Biomed Res Int; 2015; 2015():363278. PubMed ID: 25705656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of Efficacy and Safety of Blood Transfusion and Hormone Therapy in 40 Patients with Autoimmune Hemolytic Anemia].
    Yang N; Wang B; Gao F; Huang XY; Zhao XL; Wang YY; Zhang XP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1307-1311. PubMed ID: 32798417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red Blood Cell Transfusion in Patients With Autoantibodies: Is It Effective and Safe Without Increasing Hemolysis Risk?
    Park SH; Choe WH; Kwon SW
    Ann Lab Med; 2015 Jul; 35(4):436-44. PubMed ID: 26131416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+CD25+ regulatory T cells control induction of autoimmune hemolytic anemia.
    Mqadmi A; Zheng X; Yazdanbakhsh K
    Blood; 2005 May; 105(9):3746-8. PubMed ID: 15637139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.